SPRAX | VMVAX | SPRAX / VMVAX | |
Total Expense Ratio | 1.13 | 0.07 | 1,614% |
Annual Report Gross Expense Ratio | 1.32 | 0.07 | 1,886% |
Fund Existence | 21 years | 14 years | - |
Gain YTD | 5.006 | 5.532 | 90% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 164M | 30.6B | 1% |
Annual Yield % from dividends | 1.41 | 2.26 | 62% |
Returns for 1 year | 8.36 | 9.76 | 86% |
Returns for 3 years | 27.87 | 28.18 | 99% |
Returns for 5 years | 101.75 | 71.82 | 142% |
Returns for 10 years | 41.15 | 93.07 | 44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MRIGX | 34.57 | 0.24 | +0.70% |
Meridian Growth Investor | |||
MLMIX | 23.37 | 0.15 | +0.65% |
Morgan Stanley Instl Global Core I | |||
TALCX | 16.15 | 0.09 | +0.56% |
Transamerica Large Cap Value R6 | |||
PBCKX | 51.38 | 0.27 | +0.53% |
Principal Blue Chip Institutional | |||
WIEFX | 16.02 | -0.05 | -0.31% |
Boston Trust Walden International Eq |